临床微生物学档案

  • 国际标准期刊号: 1989-8436
  • 期刊 h 指数: 22
  • 期刊引用分数: 7.55
  • 期刊影响因子: 6.38
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 全球影响因子 (GIF)
  • 开放档案倡议
  • 中国知网(CNKI)
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • Scimago期刊排名
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Ebola Virus Disease: New and emerging infectious diseases

Dr. Mulang Karshenas

Human-to-human transmission fuels sporadic epidemics of severe, systemic febrile disease caused by Ebola virus strains. Even though Ebola viruses, particularly Ebola virus (EBOV), are well-known agents of viral haemorrhagic fever and there is international concern about Ebola virus disease (EVD) outbreaks, very little is known about the human immune correlates of survival and immune memory and the pathophysiology of EVD in humans. The absence of clinical and laboratory data from previous outbreaks is probably to blame for this lack of fundamental understanding of EVD's physiological characteristics. For the first time, cuttingedge laboratory equipment has been used to evaluate clinical, epidemiological, and immunological parameters in a significant number of patients as a result of the unprecedented scale of the EVD epidemic that swept through West Africa from 2013 to 2016. Human pathophysiologic and immunologic responses to filovirus infection will be summarized in this literature review.

“An emerging disease is one that has appeared in a population for the first time, or that may have existed previously but is rapidly increasing in incidence or geographic range,” states the World Health Organization (WHO). Emerging infections are defined as "infectious diseases whose incidence in humans has increased in the past two decades or threatens to increase in the near future" by the Centers for Disease Control and Prevention (CDC). These diseases, which do not discriminate based on nationality, include: new infections brought on by changes or evolution in organisms that are already present; known infections reemerging as a result of antimicrobial resistance in known agents or breakdowns in public health measures, as well as previously unrecognized infections appearing in areas undergoing ecological transformation or spreading to new geographic areas or populations.

Keywords

Ebola virus genus; Ebola Viruses; Immune memory; Human transmission; Haemorrhagic fever